These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22885161)

  • 21. The effects of 10-week core stability training on balance in women with multiple sclerosis according to Expanded Disability Status Scale: a single-blinded randomized controlled trial.
    Amiri B; Sahebozamani M; Sedighi B
    Eur J Phys Rehabil Med; 2019 Apr; 55(2):199-208. PubMed ID: 29307152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are static and functional balance abilities related in individuals with Multiple Sclerosis?
    Pau M; Porta M; Coghe G; Corona F; Pilloni G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2017 Jul; 15():1-6. PubMed ID: 28641764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.
    Caramanos Z; Francis SJ; Narayanan S; Lapierre Y; Arnold DL
    Arch Neurol; 2012 Jan; 69(1):89-95. PubMed ID: 22232348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postural control in multiple sclerosis: effects of disability status and dual task.
    Boes MK; Sosnoff JJ; Socie MJ; Sandroff BM; Pula JH; Motl RW
    J Neurol Sci; 2012 Apr; 315(1-2):44-8. PubMed ID: 22236888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
    Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic indicators for long-term disability in multiple sclerosis patients.
    Damasceno A; Von Glehn F; Brandão CO; Damasceno BP; Cendes F
    J Neurol Sci; 2013 Jan; 324(1-2):29-33. PubMed ID: 23073568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of postural control in patients with Parkinson's disease: sway ratio analysis.
    Błaszczyk JW; Orawiec R
    Hum Mov Sci; 2011 Apr; 30(2):396-404. PubMed ID: 20800915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of fatigue in multiple sclerosis.
    Bergamaschi R; Romani A; Versino M; Poli R; Cosi V
    Funct Neurol; 1997; 12(5):247-51. PubMed ID: 9439942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
    Gray O; McDonnell G; Hawkins S
    Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Extended Disability Status Scale (EDSS) as a predictor of impairments of functional activities of daily living in multiple sclerosis.
    Cohen RA; Kessler HR; Fischer M
    J Neurol Sci; 1993 Apr; 115(2):132-5. PubMed ID: 8482974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
    Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining an automatic EDSS scoring expert system for routine clinical use in multiple sclerosis.
    Gaspari M; Saletti D; Scandellari C; Stecchi S
    IEEE Trans Inf Technol Biomed; 2009 Jul; 13(4):501-11. PubMed ID: 19273014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of long-term disability in multiple sclerosis.
    Schlaeger R; D'Souza M; Schindler C; Grize L; Dellas S; Radue EW; Kappos L; Fuhr P
    Mult Scler; 2012 Jan; 18(1):31-8. PubMed ID: 21868486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis.
    Pichler A; Enzinger C; Fuchs S; Plecko-Startinig B; Gruber-Sedlmayr U; Linortner P; Langkammer C; Khalil M; Ebner F; Ropele S; Fazekas F
    Mult Scler; 2013 Feb; 19(2):167-72. PubMed ID: 22717380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.